Rationale and design of a phase II trial of dacomitinib in advanced non-small cell lung cancer patients with uncommon epidermal growth factor receptor mutations: a prospective and single arm study (DANCE study).
Molecular profiling of non-small cell lung cancer.
Plos One
Forsythe, Marika L ML; Alwithenani, Akram A; Bethune, Drew D; Castonguay, Mathieu M; Drucker, Arik A; Flowerdew, Gordon G; French, Daniel D; Fris, John J; Greer, Wenda W; Henteleff, Harry H; MacNeil, Mary M; Marignani, Paola P; Morzycki, Wojciech W; Plourde, Madelaine M; Snow, Stephanie S; Xu, Zhaolin Z
Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
Plos One
Prentice, Leah M LM; Miller, Ruth R RR; Knaggs, Jeff J; Mazloomian, Alborz A; Aguirre Hernandez, Rosalia R; Franchini, Patrick P; Parsa, Kourosh K; Tessier-Cloutier, Basile B; Lapuk, Anna A; Huntsman, David D; Schaeffer, David F DF; Sheffield, Brandon S BS
Comparison of next generation sequencing, SNaPshot assay and real-time polymerase chain reaction for lung adenocarcinoma EGFR mutation assessment.
Bmc Pulmonary Medicine
Cernomaz, Andrei-Tudor AT; Macovei, Ina Iuliana II; Pavel, Ionut I; Grigoriu, Carmen C; Marinca, Mihai M; Baty, Florent F; Peter, Simona S; Zonda, Radu R; Brutsche, Martin M; Grigoriu, Bogdan- Dragos B
Adequacy of endobronchial ultrasound-guided transbronchial needle aspiration samples processed as histopathological samples for genetic mutation analysis in lung adenocarcinoma.
Molecular And Clinical Oncology
Jeyabalan, Abiramy A; Bhatt, Nidhi N; Plummeridge, Martin J MJ; Medford, Andrew R L AR
Publication Date: 2016-01
Variant appearance in text: EGFR: 2294T>C; Val765Ala